BridgeBio Oncology Therapeutics, Inc. (BBOT) Market Cap
- 2026-09-03: Market Cap $713.55M.
- 2026-08-06: Market Cap $703.93M.
- 2026-06-30: Market Cap $610.48M.
- 2026-05-07: Market Cap $629.64M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2024-12-31 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $713.55M |
| 2026-08-06 | $703.93M |
| 2026-06-30 | $610.48M |
| 2026-05-07 | $629.64M |
| 2026-03-31 | $716.8M |
| 2026-03-02 | $806.73M |
| 2025-12-31 | $1B |
| 2025-11-07 | $971.86M |
| 2025-09-30 | $917.1M |
| 2024-12-31 | $298,357.50 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |